# Trade Mark Journal No.2026/029 17 July 2026

## WO0000001925585 (5)

Office of origin: United States of America

Date of International Registration:21 May 2026
Date of designation in the UK: 21 May 2026

The mark consists of a stylized letter "A".

Class 5
  Pharmaceutical and biological drugs for the treatment of a variety of human diseases and disorders, namely, cancer and immunological diseases or disorders; pharmaceuticals and biological drugs for use in modulating the immune system.

Arcus Biosciences, Inc.

Representative: B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP, 901 New York Avenue, NW, Washington DC 20001, UNITED STATES OF AMERICA